Stock Market News1 month Vertex Dives 11% On A ‘Worst-Case Scenario’ For Its Non-Opioid Pain Drug Investor's Business Daily
Vertex stock plummeted Thursday after the company’s pain drug proved it’s no better than a placebo in patients with lower back and hip pain.
The post Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug appeared first on I…